Latest Novavax News & Updates

See the latest news and media coverage for Novavax. We track all announcements, press releases, and industry mentions in real time, all in one place.

Novavax

Biotechnology company developing vaccines

novavax.com

Headquarters: Gaithersburg, United States
Founded year: 1987
Company type: Public company
Number of employees: 900–1,000
Industry: Pharmaceuticals

Last updated Today

Latest news about Novavax

In short: Novavax raised its annual revenue forecast following Q2 2026 results that beat estimates, driven by a strategic shift to technology licensing.

Company announcements

August 6 Novavax

Novavax announces second quarter 2026 financial results

The company highlights continued progress on its corporate growth strategy and hosts a live earnings call at 8:30 a.m. ET.

July 30 Novavax

Novavax reports Q2 2026 results and operational highlights

Total revenue declined 76% to $57 million, net loss $53 million. Raised full-year revenue guidance and reduced expense guidance. Sanofi partnership and C. difficile program highlighted.

June 24 Novavax

Novavax details R&D innovation engine to fuel partnerships

The strategy uses Matrix-M adjuvant and nanoparticle technology to generate partner data and pipeline assets.

May 6 Novavax

Novavax shares Q1 2026 financial results

They highlight progress on corporate growth strategy and invite to a live call at 8:30 a.m. ET.

Media coverage

August 6 Reuters

Pharmaceutical Executive Daily: Shah Capital s Plan to Vote Against Novavax Board Nominees | PharmExec

In today's Pharmaceutical Executive Daily, activist investor Shah Capital escalates its campaign...

Never miss news about Novavax

Track Novavax and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Novavax competitors & trending companies

Browse news for competitors to Novavax and other trending companies.